Anika to Showcase Joint Preservation and Restoration Portfolio at the 2019 Fortius International Sports Injury Conference
November 05 2019 - 4:05PM
Business Wire
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated
joint preservation and regenerative therapies company with products
leveraging its proprietary hyaluronic acid ("HA") technology
platform, today announced plans to showcase its osteoarthritis pain
management and joint preservation and restoration regenerative
therapies at the 2019 Fortius International Sports Injury
Conference (FISIC). The 2019 FISIC is being held November 6-7, 2019
in London, England and will focus on the latest practices in
orthopedics and sports injury medicine for orthopaedic surgeons,
sports physicians, radiologists, physiotherapists, and other sports
and exercise professionals. The conference will feature
multidisciplinary panels composed of over 130 experts discussing
the latest evidence-based insights in the field of sports
medicine.
“Orthopedic sports medicine and sports-related injuries are an
important focus for Anika, given our extensive portfolio of
treatments to address the joint preservation and restoration
continuum of care, from managing joint pain related to everyday and
sports-related wear and tear to repairing cartilage defects,” said
Joseph Darling, President and Chief Executive Officer of Anika
Therapeutics. “We look forward to engaging with sports medicine
specialists at this year’s FISIC, as we focus on broadening our
portfolio of regenerative therapies .”
Anika will be a silver sponsor of this year’s conference. The
company will showcase its HYALOFAST regenerative therapy, in
addition to holding physician training sessions for its
viscosupplement portfolio, including CINGAL, at booth #2.
About FISIC
The FISIC (Fortius International Sports Injury Conference) is a
multi-disciplinary conference on the theme of sports injuries for
orthopaedic surgeons, sports physicians, physiotherapists and other
healthcare professionals with an interest in sport at all levels.
FISIC 2019 will focus on the topic of sports injuries, their
prevention, treatment, recovery and return to play. The two-day
program aims to achieve a 360° view of the hot topics and
controversial issues of sports medicine. The conference is a unique
opportunity to meet and network with over 500 practicing
professionals and leaders in sports injury medicine.
About Anika Therapeutics, Inc.
Anika Therapeutics, Inc. (NASDAQ: ANIK) is a global,
integrated joint preservation and regenerative therapies company
based in Bedford, Massachusetts. Anika is committed to delivering
therapies to improve the lives of patients across a continuum of
care from osteoarthritis pain management to joint preservation and
restoration. The Company has over two decades of global expertise
commercializing more than 20 products based on its proprietary
hyaluronic acid (HA) technology platform. For more
information about Anika, please visit
www.anikatherapeutics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191105005030/en/
For Investor Inquiries: Anika Therapeutics, Inc. Sylvia Cheung,
781-457-9000 Chief Financial Officer
For Media Inquiries: W2O Group Jeremy Berrington, 312-241-1995
jberrington@w2ogroup.com
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Aug 2024 to Sep 2024
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Sep 2023 to Sep 2024